Avita Medical, Inc. income statement

In fiscal 2025, Avita Medical, Inc. reported revenue of $71.6m, up 11.5% on the year before, operating income of −$42.5m (a -59.4% margin) and net income of −$48.6m, or −$1.74 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Avita Medical, Inc.: income statement, annual
Fiscal year	2018Jun 2018	2019Jun 2019	2020Jun 2020	2021Jun 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Revenue	1	5	14	29	34	50	64	72	76
Cost of revenue	1	1	3	6	6	8	9	13	14
Gross profit	0	4	11	23	28	42	55	59	62
Research and development	6	8	9	15	14	21	20	21	20
Selling and marketing	5	13	16	15	22	37	58	53	50
General and administrative	9	15	33	22	23	28	33	27	26
Operating income	−14	−26	−43	−27	−28	−43	−57	−43	−35
Interest expense	0	0	0	0	0	1	5	5	5
Provision for credit losses	0	0	0	0	−0	0	0	−0	0
Income before tax	−14	−25	−42	−27	−27	−35	−62	−49	−43
Income tax	−1	−0	0	0	0	0	0	0	0
Net income	−13	−25	−42	−27	−27	−35	−62	−49	−43
Diluted EPS	$1.37	$1.56	$2.07	$1.17	$1.07	−$1.40	−$2.39	−$1.74	−$1.43
Diluted shares (average)	9m	16m	20m	23m	25m	25m	26m	28m	30m
EBITDA	−14	−25	−42	−26	−27	−42	−55	−40	−33

US$ millions unless shown otherwise. Fiscal quarters.

Avita Medical, Inc.: income statement, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Revenue	20	18	19	18	17	18	19	22
Cost of revenue	3	2	3	3	3	3	4	4
Gross profit	16	16	16	15	14	14	16	18
Research and development	5	5	6	5	4	6	6	5
Selling and marketing	15	14	15	14	12	12	13	14
General and administrative	10	7	6	7	7	7	6	6
Operating income	−14	−10	−12	−11	−9	−10	−9	−7
Interest expense	1	1	1	1	1	1	1	1
Provision for credit losses	−0	−0	−0	0	−0	0	0	0
Income before tax	−16	−12	−14	−10	−13	−12	−11	−8
Income tax	−0	0	0	0	0	−0	−0	0
Net income	−16	−12	−14	−10	−13	−12	−11	−8
Diluted EPS	−$0.62	−$0.44	−$0.53	−$0.38	−$0.46	−$0.37	−$0.35	−$0.25
EBITDA	−14	−10	−11	−11	−9	−10	−8	−6

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: ELMD vs RCEL PDEX vs RCEL RCEL vs TELA

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Avita Medical, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Avita Medical, Inc.